Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30005670HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30000523HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30000145HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30085770HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30075852HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30085771HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30028372HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30028373HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30028374HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30028375HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TCGA Plot Options
Drug Information
GeneCHUK
DrugBank IDDB00244
Drug NameMesalazine
Target IDBE0004655
UniProt IDO15111
Regulation Typeinhibitor
PubMed IDs11151876; 12950415; 11054378
CitationsBantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K: Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol. 2000 Dec;95(12):3452-7.@@Allgayer H: Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment Pharmacol Ther. 2003 Sep;18 Suppl 2:10-4.@@Weber CK, Liptay S, Wirth T, Adler G, Schmid RM: Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000 Nov;119(5):1209-18.
GroupsApproved
Direct ClassificationAminobenzoic acids
SMILESNC1=CC(C(O)=O)=C(O)C=C1
Pathways
PharmGKBPA450384
ChEMBLCHEMBL704